Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.2.13 (
aldolase
)
3,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Two distinct types of cDNAs for fructose-1,6-bisphosphate (FBP)
aldolase
, Ce-1 and Ce-2, have been isolated from nematode Caenorhabditis elegans, and the respective recombinant
aldolase
isozymes, CE-1 and
CE-2
, have been purified and characterized. The Ce-1 and Ce-2 are 1282 and 1248 bp in total length, respectively, and both have an open reading frame of 1098 bp, which encodes 366 amino acid residues. The entire amino acid sequences deduced from Ce-1 and Ce-2 show a high degree of identity to one another and to those of vertebrate and invertebrate aldolases. The highest sequence diversity was found in the carboxyl-terminal region that corresponds to one of the isozyme group-specific sequences of vertebrate
aldolase
isozymes that play a role in determining isozyme-specific functions. Southern blot analysis suggests that CE-1 and
CE-2
are encoded by different genes. Concerning general or kinetic properties,
CE-2
is quite different from CE-1. CE-1 exhibits unique characteristics which are not identical to any
aldolase
isozymes previously reported, whereas
CE-2
is similar to vertebrate aldolase C. These results suggest that
CE-2
might preserve the properties of a progenitor
aldolase
with a moderate preference for FBP over fructose 1-phosphate (F1P) as a substrate, whereas CE-1 evolved to act as an intrinsic enzyme that exhibits a much broader substrate specificity than dose
CE-2
.
...
PMID:Caenorhabditis elegans has two isozymic forms, CE-1 and CE-2, of fructose-1,6-bisphosphate aldolase which are encoded by different genes. 905 53